CeleryKills

My science feed continues to give essay seedlings, especially around emergent chemistry and medicine. I was looking at my feed a week ago and saw something pop up in both the emergent chemistry/abiogenesis filter and the nanotechnology/medicine filter, and that unusual to see that too often, so I had to take a look. So, some research later and a talk with my niece, the biochemist, and bingo another essay topic was discovered.

The overlap turned out to be a paper describing a two dimensional single atom nanozyme designed for glioblastoma surgery and treatment. The system functions as both a guide and an actor. It helps surgeons visualize tumor cells at extraordinarily fine scales and then switches roles into a catalytic therapeutic platform after the visible tumor has been removed (Shi et al., Spatiotemporal-switchable 2D NIR-II Single-Atom Nanozyme, 2025).

That is a modern medical technology story. It is also, in a strangely recognizable way, an origin of life story.

One of the recurring themes in abiogenesis research is that chemistry becomes interesting when it stops being uniform. Life does not emerge from well stirred homogeneity. It emerges from gradients, pockets, surfaces, crystal faces, mineral boundaries, and catalytic microenvironments where certain reactions become more likely than others. Mineral catalysts, transition metal sulfides, and structured surfaces have long occupied center stage in theories of chemical evolution because they provide local rules that channel otherwise chaotic chemistry (Li, Minerals as Prebiotic Catalysts for Chemical Evolution, 2022).

Regular readers have probably noticed that I keep circling back to catalytic microenvironments. In Catalysts, Origins, and the Quiet Continuity of Chemistry, I argued that the most interesting story in origins research is not the appearance of a particular molecule but the emergence of places where certain molecules become statistically favored. Chemistry is always happening, but chemistry that accumulates, reinforces itself, and pushes toward greater complexity requires structure. Catalysts, mineral surfaces, crystal defects, and microscopic compartments act as filters. They do not create possibility from nothing. They simply tilt the odds. Once the odds are tilted often enough, surprising things begin to happen.

I ended up approaching the same idea from a different angle in Where Chemistry Learns to Persist. There the focus was less on origins and more on continuity. A reaction that occurs once is chemistry. A reaction that helps create the conditions for its own repetition begins to look like something else entirely. Persistence emerges when matter encounters environments that stabilize useful pathways while suppressing unproductive ones. Whether we are talking about hydrothermal pores, metal sulfide surfaces, clay minerals, or nanoscale catalytic structures, the underlying theme remains remarkably consistent. Complexity does not appear because the universe suddenly becomes creative. It appears because local environments learn how to retain chemical successes and discard failures. That is a pattern I keep seeing, and it is hard not to notice it again when reading about modern nanozymes and engineered catalytic systems.

What strikes me is that nanochemistry seems to be rediscovering many of those same principles, albeit with better engineering and much more expensive equipment.

Nanozymes represent perhaps the clearest example. The field began when researchers discovered that certain nanoparticles could mimic enzymatic behavior. Instead of building catalysts out of folded proteins, they could build them from iron oxide particles, metal clusters, carbon nanostructures, and hybrid materials. These systems displayed enzyme-like catalytic activity while avoiding many of the fragilities of biological enzymes (Jeyachandran et al., Recent Development and Application of Nanozyme Artificial Enzymes, 2023; Zhang et al., Nanozymes for Nanohealthcare, 2024).

That sounds technical. I think it is more revealing to frame it differently.

Chemists spent decades trying to make chemistry more machine-like. Biology spent billions of years making machines from chemistry. Eventually the two trajectories were bound to collide.

The history of nanozymes and nanomachines is largely the history of human engineers discovering that biology had already encountered the same design constraints. Catalysts need selectivity. Therapeutics need targeting. Molecular processes need feedback. Reactions need energy management. Nature solved these problems with enzymes, membranes, molecular motors, protein assemblies, and metabolic networks. Modern nanochemistry increasingly borrows those solutions rather than attempting to invent completely new ones (Guo et al., Nanozymes Expanding the Boundaries of Biocatalysis, 2025; Pandey et al., Can Nanozymes Make the Leap to the Clinic?, 2026).

The glioblastoma nanozyme paper illustrates this convergence particularly well. The system is not merely a passive drug carrier. It senses. It localizes. It responds to external stimulation. It changes operational mode depending on context. Those characteristics sound suspiciously biological. Not alive, certainly, but increasingly life-adjacent. The machine works because researchers deliberately designed catalytic behavior, localization behavior, optical behavior, and therapeutic behavior into a unified nanoscale architecture (Shi et al., 2025).

My niece made a comment that stuck with me. She observed that modern biochemistry often feels less like studying organisms and more like studying information processing systems made of molecules. That resonates with what I see happening in nanotechnology. Researchers are no longer merely asking whether a particle can carry a drug. They are asking whether a chemical system can make decisions, however primitive. Can it activate only in a tumor? Can it respond to local chemistry? Can it preferentially catalyze one pathway over another?

Those are exactly the kinds of questions abiogenesis researchers ask when investigating how lifeless chemistry became organized chemistry.

Even the growing interest in mineral nanozymes creates a loop back to origins research. Some current origin of life models emphasize catalytic mineral nanoparticles as potential intermediaries between simple geochemistry and true biochemistry. In those frameworks, naturally occurring nanoscale catalysts may have accelerated reactions, concentrated molecules, and promoted increasing chemical complexity long before the first cell appeared (Jin, Nanozymes Hypothesis for the Origin of Life, 2026; Li, 2022).

So here we are, building synthetic nanozymes for cancer therapy while simultaneously debating whether nature used analogous structures four billion years ago. The symmetry is difficult to miss. One field is trying to understand how molecular systems became functional. The other is trying to engineer functionality into molecular systems.

Science fiction has been playing with this overlap for decades. In Michael Crichton’s Prey, swarms of autonomous nanoparticles blur the line between machine and organism. Neal Stephenson’s The Diamond Age imagines a mature nanotechnological civilization in which matter becomes programmable. Greg Bear’s Blood Music pushes even further, envisioning engineered biological entities that evolve beyond their original design. The common theme is not simply smaller machines. It is chemistry gaining agency.

Arthur C. Clarke famously wrote, “Any sufficiently advanced technology is indistinguishable from magic.” In nanomedicine, a more relevant variation might be that any sufficiently advanced chemistry begins to resemble biology.

Where does this lead?

Cellular surgery seems like the obvious destination. Instead of removing tissue at the organ scale, future nanozymes and catalytic nanomachines could operate at cellular resolution, identifying malfunctioning structures and correcting them in place. Gene modification may evolve beyond current editing systems toward chemically guided molecular repair networks that seek out specific defects and rebuild damaged genetic sequences. Regenerative medicine could move from supplying replacement cells to directing coordinated local growth through catalytic signaling systems distributed throughout injured tissues.

Perhaps the most interesting possibility is guided regeneration. Rather than forcing the body to heal, nanochemical systems may eventually create the precise microenvironments that encourage the body to heal itself. Biology already knows how to build a liver, reconnect nerves, and organize tissues. The challenge is not inventing those capabilities. The challenge is persuading the body to use them at the right time and place.

Is that medicine, chemistry, or developmental biology?

I increasingly suspect the distinction is fading.

For years, nanotechnology was often marketed as miniature engineering. Looking at the field today, especially through the lens of nanozymes, it feels more accurate to call it synthetic biochemistry. Researchers continue shrinking devices, but more importantly they are absorbing lessons from catalytic networks, spatial organization, compartmentalization, and emergent function. They are learning from cells. They are learning from enzymes. They are learning from the same chemical principles that abiogenesis researchers believe transformed a young planet into a living one.

The deeper nanochemistry goes, the less it resembles machinery built from steel and gears and the more it resembles the old story written into biology itself. The funny thing is that this should not surprise us. Life was the first nanotechnology. We are only now starting to understand its design notes.

References

• Jeyachandran, S. et al. Recent Development and Application of “Nanozyme” Artificial Enzymes: A Review. Biomimetics, 2023.
• Jin, Y. Nanozymes Hypothesis for the Origin of Life. Discussed in ScienceDaily, 2026.
• Li, Y. Minerals as Prebiotic Catalysts for Chemical Evolution towards the Origin of Life. IntechOpen, 2022.
• Pandey, N. K. et al. Can Nanozymes Make the Leap to the Clinic? Advances, Hurdles, and Prospects. Trends in Biotechnology, 2026.
• Shi, B. et al. Spatiotemporal-switchable 2D NIR-II Single-Atom Nanozyme for Single-Cell-Level Surgical Navigation and Glioblastoma Phototherapy. Science Translational Medicine, 2025.
• Zhang, Y. et al. Nanozymes for Nanohealthcare. Nature Reviews Methods Primers, 2024.
• Guo, et al. Nanozymes Expanding the Boundaries of Biocatalysis. Nature Communications, 2025.
• CeleryKills. Catalysts, Origins, and the Quiet Continuity of Chemistry. Celery Kills, March 25, 2026. Available at: https://celerykills.com/2026/03/25/catalysts-origins-and-the-quiet-continuity-of-chemistry/
• CeleryKills. Where Chemistry Learns to Persist. Celery Kills, July 27, 2026. Available at: https://celerykills.com/2026/07/27/where-chemistry-learns-to-persist/